ALYSSA SMITH: Open Payments
NPI 1609654516 · MCMINNVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 47 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $185 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $153 |
| Lilly USA, LLC | 5 | $94 |
| Novo Nordisk Inc | 4 | $92 |
| PFIZER INC. | 4 | $88 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Viatris Specialty LLC | 2 | $48 |
| Exact Sciences Corporation | 2 | $46 |
| Corcept Therapeutics | 2 | $43 |
Products named: EVENITY, KISUNLA, TRELEGY ELLIPTA, ELIQUIS, XIFAXAN, REXULTI, Ozempic, YUPELRI.
Industry payments across OR — which companies pay providers there.
